Literature DB >> 10341287

Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development.

K Ejeskär1, R M Sjöberg, P Kogner, T Martinsson.   

Abstract

In neuroblastoma, a childhood tumor of neural crest, a tumor suppressor gene located at 1p36 has been implicated to play a major role in tumor aggressiveness and clinical prognosis. We have examined 30 different staged primary neuroblastoma tumors using RT-PCR, for expression of the p73 gene located at 1p36.3, and its correlation to other clinical and biological features of these tumors. No correlation between expression of p73 and MYCN-amplification or 1p-deletion could be found, five of ten 1p-deleted tumors showed detectable levels of p73, and no mutations could be detected, neither in the retained alleles nor in any other parts of the material. In five 1p-deleted cases the origin of deletion were determined, two were of maternal and three of paternal origin. Both tumors with maternal 1p-loss showed detectable levels of p73, whereas the three with paternal loss did not. This suggests that p73 is expressed from the paternal allele only in advanced staged neuroblastoma tumors. Furthermore, it suggests absence of correlation between p73-expression and stage in these tumors. In conclusion, we could find no evidence for p73 being the neuroblastoma tumor suppressor gene in 1p36.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10341287     DOI: 10.3892/ijmm.3.6.585

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  1p36.32 rearrangements and the role of PI-PLC η2 in nervous tumours.

Authors:  Vincenza Rita Lo Vasco
Journal:  J Neurooncol       Date:  2010-09-29       Impact factor: 4.130

2.  A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.

Authors:  C Gaiddon; M Lokshin; J Ahn; T Zhang; C Prives
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  N-myc modulates expression of p73 in neuroblastoma.

Authors:  Xiaoxiang Zhu; Katharina Wimmer; Rork Kuick; Barbara J Lamb; Stephanie Motyka; Rama Jasty; Valerie P Castle; Samir M Hanash
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

4.  Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.

Authors:  Katarina Ejeskär; Cecilia Krona; Helena Carén; Faten Zaibak; Lingli Li; Tommy Martinsson; Panayiotis A Ioannou
Journal:  BMC Cancer       Date:  2005-12-16       Impact factor: 4.430

5.  Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours.

Authors:  F Abel; R-M Sjöberg; K Ejeskär; C Krona; T Martinsson
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

6.  Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.

Authors:  D Astuti; M Morris; C Krona; F Abel; D Gentle; T Martinsson; P Kogner; H P H Neumann; R Voutilainen; C Eng; P Rustin; F Latif; E R Maher
Journal:  Br J Cancer       Date:  2004-11-15       Impact factor: 7.640

7.  Silencing E3 Ubiqutin ligase ITCH as a potential therapy to enhance chemotherapy efficacy in p53 mutant neuroblastoma cells.

Authors:  Jinhong Meng; Aristides D Tagalakis; Stephen L Hart
Journal:  Sci Rep       Date:  2020-01-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.